No Record Found
Sector
PharmaceuticalsOpen
₹9.56Prev. Close
₹9.62Turnover(Lac.)
₹0.27Day's High
₹10.1Day's Low
₹9.5652 Week's High
₹13.352 Week's Low
₹9.1Book Value
₹10.59Face Value
₹2Mkt Cap (₹ Cr.)
60.44P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 12.32 | 14.24 | 13.67 | 7.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 33.1 | 26.22 | 23.04 | 28.09 |
Net Worth | 45.42 | 40.46 | 36.71 | 35.45 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1.26 | 22.75 | 31.07 | 28.91 |
yoy growth (%) | -94.43 | -26.75 | 7.45 | 19.58 |
Raw materials | -0.73 | -23.93 | -25.41 | -15.96 |
As % of sales | 57.65 | 105.17 | 81.78 | 55.2 |
Employee costs | -1.15 | -1.48 | -1.36 | -1.05 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -3.68 | -3.93 | 1.14 | 2.82 |
Depreciation | -0.72 | -1.34 | -1.36 | -1.33 |
Tax paid | 1.8 | 0.25 | -0.2 | -0.64 |
Working capital | -7.21 | -2.48 | -0.12 | 5.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -94.43 | -26.75 | 7.45 | 19.58 |
Op profit growth | -63.94 | -488 | -76.84 | 74.74 |
EBIT growth | -10.72 | -184.93 | -35.91 | 109.75 |
Net profit growth | -48.73 | -491.44 | -57.03 | 75.27 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / WTD
Dhananjaya Alli
Executive Director & MD
Murali Meraga
E D & Wholetime Director
Pavan Sathvik Gilaka
Non Executive & Non WTD
Stanley Prabhakar Reddy
Non Executive & Non WTD
Mallem Hanumantha Rao
Non Executive & Non WTD
Umakanth Katta
Non Executive & Non WTD
Divakar Reddy Yerrabommanahalli
Independent Non Exe. Director
Umesh Virupakah Banakar
Independent Non Exe. Director
Divya Bhavani Chakravarthula
Independent Non Exe. Director
Naga Raja Madineni
Independent Non Exe. Director
Madhu Sudan Anchi
Independent Non Exe. Director
Swapna Priya Gunduboina
Independent Non Exe. Director
Anumala Ravi Chandra Kumar
Independent Non Exe. Director
Rama Mohan Manamasa
Company Sec. & Compli. Officer
Barkha Jain
Plot No 10to14 16to20 APIIC,
Industrial Estate Chotyal,
Telangana -
Tel: 91-09291015956
Website: http://www.vistapharmaceuticals.com
Email: admin.hyd@vistapharmaceuticals.com
1-2-285,
Domalguda, J B Apartments,
Hyderabad - 500 029
Tel: 91-40-27642217 /2763
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Compan...
Read More
Reports by Vista Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.